Health
Sinovac’s COVID-19 vaccine induces quick immune response – study – Reuters
Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had…
SINGAPORE/BEIJING (Reuters) – Sinovac Biotechs experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
…
-
General14 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General23 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General21 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News13 hours agoE-Scooter accident | Noosa Today